Nightingale Health Plc and Suomen Terveystalo Oy have signed an agreement that expands the partnership between the two companies to cover Terveystalo's occupational health services. Nightingale Health announced a letter of intent to expand the partnership on 30 June 2023, and the now signed agreement incorporates Nightingale Health's blood analysis technology to regular health checks performed as part of Terveystalo's occupational Health services. Terveystalo will use Nightingale Health's risk prediction models and blood values in regular health checks and integrate them into the daily work of Terveystalo's Occup health doctors, nurses, and laboratories.

The agreement is a significant achievement for Nightingale Health, as it is the first agreement where the company's blood analysis technology will be part of an occupational health system on a national scale. Terveystalo is Finland's largest occupational health service provider, and it offers occupational health services to more than 27,000 companies and other organizations. Its occupational health services cover approximately 700,000 individuals, a significant proportion of Finland's total workforce.

Using Nightingale Health's risk predict models in regular health checks makes it achievable to prevent diseases on a population-level. Nightingale Health's blood biomarker-based risk prediction models can detect disease risks for several common chronic diseases from a single blood sample with a single test. A group of Terveystalo's medical professionals have selected the risk prediction to cover eight critical chronic diseases: myocardial infarction; cardiovascular disease; cardiovascular disease; type 2 diabetes; cardiovascular disease; liver fibrosis and cirrhosis; chronic kidney disease; COPD; lung cancer; and alcoholic liver disease.

The ability to identify the risks for several common diseases from a single sample in one test is a significant improvement compared to current risk assessments, which are conducted based on individual blood values, clinical examination, and patient interviews. By including Nightingale Health's risk detection models in regular health checks, health risks are identified well in advance and actions can be started to prevent diseases. Terveystalo will also use Nightingale Health's Blood analysis technology to conduct follow-up examinations, which quantify the impact of the actions prescribed by healthcare professionals based on existing guidelines.

Since Terveystalo's occupationalhealth services serve a significant part of Finland's working-age population, reducing the risk of illness positively affects the whole population's health.